Cerebellar Hypoplasia and Treatment Course of a Two‐Month‐Old Infant With KCNQ2 Epileptic Encephalopathy Due to a De Novo Variant and Review of the Literature
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63909 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Dilek Cebeci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pediatric Neurology, Gazi University, Ankara, Turkey. Hauptthemen laut MEDLINE: Cerebellum, Epilepsy, KCNQ2 Potassium Channel, Nervous System Malformations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
In this paper, we report the treatment course, magnetic resonance imaging (MRI), and electroencephalography (EEG) findings of a two‐month‐old girl with KCNQ2 epileptic encephalopathy caused by a de novo variant. The patient started having seizures 2 days postnatally. Despite treatment with phenobarbital, phenytoin, levetiracetam, topiramate, clonazepam, vigabatrin, clobazam, and pyridoxine, she continued to have 10 or more seizures per day. EEG recordings showed multifocal epileptiform discharges with diffuse background slowing. MRI revealed left cerebellar hypoplasia. After lacosamide administration, the severity and frequency of seizures decreased by 80%. EEG recordings showed a significant improvement. A de novo heterozygous variant of c.1681C>A (p.Pro561Thr) in the KCNQ2 gene was detected. After carbamazepine add‐on treatment, the patient achieved seizure‐free status for about 2 years. This case demonstrates the efficacy of lacosamide against KCNQ2 epileptic encephalopathy. To our knowledge, this is the first report to document the association between cerebellar hypoplasia and KCNQ2 variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Pediatric Neurology, Gazi University, Ankara, Turkey.
- Department of Medical Genetics, Ankara City Hospital, Ankara, Turkey.
ORCID-Profile: Dilek Cebeci, Busranur Cavdarli
Zitieren
APA
Cebeci, D., Cavdarli, B., Ozbudak, P., Arhan, E., Gucuyener, K., & Demir, E. (2025). Cerebellar Hypoplasia and Treatment Course of a Two‐Month‐Old Infant With KCNQ2 Epileptic Encephalopathy Due to a De Novo Variant and Review of the Literature. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63909
Vancouver
Cebeci D, Cavdarli B, Ozbudak P, Arhan E, Gucuyener K, Demir E. Cerebellar Hypoplasia and Treatment Course of a Two‐Month‐Old Infant With KCNQ2 Epileptic Encephalopathy Due to a De Novo Variant and Review of the Literature. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63909
BibTeX
@article{Cebeci2025,
author = {Cebeci, Dilek and Cavdarli, Busranur and Ozbudak, Pinar and Arhan, Ebru and Gucuyener, Kivilcim and Demir, Ercan},
title = {Cerebellar Hypoplasia and Treatment Course of a Two‐Month‐Old Infant With KCNQ2 Epileptic Encephalopathy Due to a De Novo Variant and Review of the Literature},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63909}
}
EUVIMED